Welcome to TexasLifeScience.com
TexasLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Texas
Are you considering a move to Texas? Relocating your business to
Texas? Starting a company? Or just interested in the Old Line State?
This section will answer many of your questions regarding the life science industry in Alabama, the state's economy,
tax structure and cost of living, education, transportation, climate, recreational opportunities, history, industry resources,
and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Myozyme produced at the 2000 L bioreactor scale to receive accelerated approval Genzyme announced that the FDA plans an Accelerated Approval for Myozyme(R) (alglucosidase alfa) produced at the 2000 L bioreactor scale for the treatment of Late Onset Pompe disease.
Genzyme Corporation November 17, 2008
- Lilly licenses U.S. rights for tadalafil PAH indication to United Therapeutics Eli Lilly and Company and United Therapeutics announced that the two companies have entered into a license and a supply agreement related to the U.S. commercialization rights for the pulmonary arterial hypertension (PAH) indication of Lilly's molecule, tadalafil.
United Therapeutics Corporation November 17, 2008
- Luminex Corporation announces first commercial shipment of FLEXMAP 3D systems Luminex announced the commercial sale and shipment of the first FLEXMAP(TM) 3D system manufactured in Austin, Texas. Full market release of the instrument is expected in the first quarter of 2009.
Luminex Corporation November 14, 2008
- Pfizer launches global regenerative medicine research unit Pfizer announced the launch of a new research unit known as Pfizer Regenerative Medicine. This independent research unit will build on recent scientific progress in understanding the biology of stem cells.
Pfizer Inc. November 14, 2008
- New antibiotic against serious infections - receives first approval in Europe Swissmedic, the Swiss agency for therapeutic products, has approved ZEVTERA(TM) (ceftobiprole medocaril) for the treatment of complicated skin and soft tissue infections, including diabetic foot infections which have not spread to the bone.
Johnson & Johnson November 13, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Texas's BioHistory
Why is there a biotechnology industry in Texas? Will the industry continue
to grow in Texas? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Texas BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Texas.
More...
BioEvolution Posters
More...
November is American Diabetes Month
Diabetes is a leading cause of kidney failure, blindness and amputations, and a major cause of heart
disease and stroke. Nearly 24 million Americans have diabetes, and about one quarter (or 5.7 million)
of them don't know that they have the disease. Millions more are at risk of developing diabetes.
Diabetes is a costly disease associated with serious complications and premature death. It is a major
cause of heart disease and stroke and a leading cause of leg and foot amputations unrelated to injury,
kidney failure, and new blindness in adults.
More...
BioFact
(1883) - Francis Galton's Enquiries into Human Faculty introduces the term eugenics and suggests that humans can be improved by selective breeding.
It's a Small World
|
| |
Lactobacillus Bacteria
| |
Science Quote
"If your experiment needs statistics, then you ought to have done a better experiment."
| - |
Ernest Rutherford, English physicist
|
|
(1871- 1937)
|
|
